 effects benzodiazepine-receptor antagonists partial inverse agonists acute hepatic encephalopathy rat benzodiazepine-receptor partial inverse agonists Ro Ro benzodiazepine-receptor antagonist flumazenil hepatic encephalopathy due ischemia Significant improvement clinical grade hepatic encephalopathy electroencephalographic abnormalities administration benzodiazepine-receptor partial inverse agonists comatose rats spontaneous reflex injection drug slight improvement clinical hepatic encephalopathy grade administration mg/kg flumazenil present data role increased gamma-aminobutyric acid-ergic tone pathogenesis acute hepatic encephalopathy rationale trials benzodiazepine-receptor partial inverse agonists consciousness hepatic encephalopathy humans near future